Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Cmb.Tech NV

CMBT
Energy · Oil & Gas Midstream

Cmb.Tech NV's price has outrun its earnings. +77.3% in a year against EPS −84.2% — the market is paying now for delivery later.

The sharpest disagreement: the price moved +77.3% in a year while annual EPS moved −84.2% — the difference is re-rating, and re-rating has to be repaid with earnings.

The price is in a confirmed uptrend (22 weeks in) while the P/E sits at the 76th percentile of its own 4-year range. Underneath, the last four quarters read improving — profit +825.0% year on year, and 93% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.

Stage
Turning around
fundamental trajectory, 12 quarters
Price
$15.9
+77.3% 1Y
P/E
9.6×
76th pctile
of its own 4-year range
Revenue (Mar 26)
$0.5 B
+116.7% YoY
Profit (Mar 26)
$0.4 B
+825.0% YoY
Operating margin
84.6%
+42.9 pp YoY
ROE
17%
FY25
ROIC
5.9%
vs WACC 6.3% → −0.4 pp
Cash conversion
93%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Cmb.Tech NV trades at $15.9, in a confirmed uptrend and 22 weeks into that stage. That is +24.9% against its own 200-day average. It sits at 89% of a 52-week range of $8 to $17. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 5 straight weeks.

Today the stock is in a confirmed uptrend — week 22 of stage 2. At $15.9 it trades +24.9% versus its 200-day average and sits at 89% of its 52-week range ($8–$17).

Aug 26: $15.9 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+24.9% versus the 200-day line, week 22 of stage 2
Price50-day avg200-day avg
S3S4S3S2$21.7$18.1$14.4$10.7$7.1$$16$13Jul 23Apr 24Jan 25Oct 25Aug 26
S3S4S3S2$21.7$18.1$14.4$10.7$7.1$$16$13Jul 23Jan 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (527 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Aug 26

Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +83% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 5 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Cmb.Tech NV trades at 9.6× P/E, at the pricey end of its own range (76th percentile). Its long-run median P/E is 5.3×, measured across 3.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 9.6× is at the pricey end of its own range (76th percentile), against a long-run median of 5.3× measured over 3.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 9.6× vs a 5.3× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 3.6-year window; loss-period spikes above 16× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (76th percentile)
P/EMedianEPS (TTM) (quarterly)
17.2×$6.513.0×$4.98.8×$3.24.6×$1.60.4×$0.0×$9.89×$2Jan 23Nov 23Oct 24Sep 25Aug 26
17.2×$6.513.0×$4.98.8×$3.24.6×$1.60.4×$0.0×$9.89×$2Jan 23Oct 24Aug 26
PEG 0.85 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Computed here as quarter-end P/E ÷ trailing-twelve-month EPS growth (only quarters with positive growth), because a reported quarterly PEG is not held for this stock. Last 5 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
1.1×0.8×0.5×0.3×0.0××0.85×Dec 23Mar 24Jun 24Sep 24Dec 24
1.1×0.8×0.5×0.3×0.0××0.85×Dec 23Jun 24Dec 24
P/E
9.6×
76th percentile of 4y
PEG
n/m
not derivable — 3-year earnings growth unavailable

🚨 Why the multiple sits where it does: over the past year annual EPS moved −84.2% against a +77.3% price move — the price outran earnings, pushing the multiple UP its own range.

The price move, decomposed: over 3y, of the −2.3%/yr price move, ~−18.0%/yr came from earnings growth and ~+15.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Turning around

Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Cmb.Tech NV reads as turning around on its fundamental arc. Turning around — profit growth swung from −83.9% at the trough to +14.6% off a 1-quarter-old trough, ROCE lifting at 11.8%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +77.7% in FY25, profit −83.9% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
113%331%76%219%39%108%2.4%0.0%−34%−115%%%77.7%−83.9%FY21FY23FY25
113%331%76%219%39%108%2.4%0.0%−34%−115%%%77.7%−83.9%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit accelerating
RevenueProfitEPS
188%331%130%218%73%106%15%−6.7%−43%−119%%%107.4%14.6%−25.1%Jun 23Sep 24Mar 26
188%331%130%218%73%106%15%−6.7%−43%−119%%%107.4%14.6%−25.1%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
23%19%15%12%7.9%%11.8%Jun 23Dec 23Sep 24Jun 25Mar 26
23%19%15%12%7.9%%11.8%Jun 23Sep 24Mar 26
Revenue growth
Rising
latest +107.4% · span −26.9% to +172.3%
Profit growth
Rising
latest +14.6% · span −88.2% to +290.9%
EPS growth
Recovering
latest −25.1% · span −87.5% to +322.8%
ROCE
Rising
latest 11.8% · span 8.9%–21.7%

Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+77.7%+25.2%
Profit−83.9%−11.2%
EPS−84.2%−11.5%
Stock price+77.3%−2.3%+14.5%+6.2%
Revenue YoY (Mar 26)
+116.7%
latest quarter vs a year ago
Profit YoY (Mar 26)
+825.0%
latest quarter vs a year ago
Revenue 10y
41.2%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

64.5/100 — rank 4 of 30 in Oil & Gas Midstream · 71% evidence confidence

Cmb.Tech NV scores 64.5 out of 100 against the 30 companies it is compared with in Oil & Gas Midstream, ranking 4. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 24.5 + 13.2 + 11.2 + 15.6 = 64.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Cmb.Tech NV reported $0.5 B of revenue in the Mar 26 quarter, +116.7% year on year. That is the 4th straight quarter of year-on-year growth. Over 4 years it has compounded at 41.2% a year. The last full year, FY25, came in at $1.7 B. The last four reported quarters add to $2.0 B.

FY25 revenue came in at $1.7 B (+77.7% on the year), capping 4 years at 41.2% compound. The latest quarter (Mar 26) printed $0.5 B, +116.7% year on year — the 4th consecutive quarter of year-over-year growth.

FY25 revenue $1.7 B (+77.7% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
41.2% a year over 4 years
RevenueYoY growth
1.8113%1.476%0.939%0.52.4%0.0−34%$ B%$2B77.7%FY21FY23FY25
1.8113%1.476%0.939%0.52.4%0.0−34%$ B%$2B77.7%FY21FY23FY25
Mar 26: $0.5 B (+116.7% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
4th straight quarter of growth
Revenue (quarterly)YoY growth
0.6171%0.5117%0.364%0.29.6%0.0−44%$ B%$1B116.7%Jun 23Sep 24Mar 26
0.6171%0.5117%0.364%0.29.6%0.0−44%$ B%$1B116.7%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +108.4% growth against the decade's 41.2% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +107.4% over the last 4 quarters against +30.8%/yr over the last 8 — accelerating; TTM profit +14.6% vs −36.9%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Cmb.Tech NV's operating margin is 84.6% in the Mar 26 quarter, +42.9 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −66.7% to 106.4%. The current quarter sits inside that band.

The latest quarter's operating margin is 84.6%, +42.9 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −66.7%–106.4%.

Why the margin moved: operating margin went +42.9 pp year on year while gross margin went +1.6 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY25: 33.5% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a −66.7–106.4% band over 5 years
operating marginYoY change (pp)
120%115%70%64%20%14%−30%−36%−81%−87%%%33.5%−72.9%FY21FY23FY25
120%115%70%64%20%14%−30%−36%−81%−87%%%33.5%−72.9%FY21FY23FY25
Mar 26: 84.6% operating margin (+42.9 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
227%180%174%86%120%−8.6%67%−103%13%−197%%%84.6%42.9%Jun 23Sep 24Mar 26
227%180%174%86%120%−8.6%67%−103%13%−197%%%84.6%42.9%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Cmb.Tech NV earned $0.4 B of net profit in the Mar 26 quarter, +825.0% year on year. Full-year FY25 profit was $0.1 B. That is 71.2% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 1 of the last 12 reported quarters were loss-making.

Mar 26 profit was $0.4 B, +825.0% year on year. On the full year, FY25 printed $0.1 B (−83.9%).

FY25 profit $0.1 B (−83.9% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
1.0363%0.6243%0.3123%−0.10.0%−0.4−117%$ B%$0B−83.9%FY21FY23FY25
1.0363%0.6243%0.3123%−0.10.0%−0.4−117%$ B%$0B−83.9%FY21FY23FY25
Mar 26: $0.4 B (+825.0% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.5899%0.4630%0.2360%0.190%−0.1−180%$ B%$0B825%Jun 23Sep 24Mar 26
0.5899%0.4630%0.2360%0.190%−0.1−180%$ B%$0B825%Jun 23Sep 24Mar 26

Why profit moved: revenue contributed +116.7% and the margin +42.9 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.

Pace comparison, last four quarters: profit +159.8% vs revenue +108.4%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 93% of Cmb.Tech NV's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.4 B of operating cash against $0.1 B of profit. After $1.0 B of capital spending, $−0.6 B was left as free cash.

FY25: operating cash of $0.4 B against reported profit of $0.1 B, leaving free cash of $−0.6 B after $1.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 93% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $0.4 B vs profit $0.1 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
93% of 3-year profit arrived as cash
Operating cashNet profitFree cash
1.00.50.1−0.3−0.8$ B$0B$0B$−1BFY21FY23FY25
1.00.50.1−0.3−0.8$ B$0B$0B$−1BFY21FY23FY25
Dec 25: operating cash $0.2 B = 256% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.28754%0.21558%0.14361%0.07164%0.00−32%$ B%$0B256%Mar 23Jun 24Dec 25
0.28754%0.21558%0.14361%0.07164%0.00−32%$ B%$0B256%Mar 23Jun 24Dec 25

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Cmb.Tech NV does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $2.0 B over the last 3 years. Averaged over those years that is 39.9% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $2.0 B over the last 3 fiscal years.

FY25: capex $1.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
1.20.90.60.30.0$ B$1BFY21FY23FY25
1.20.90.60.30.0$ B$1BFY21FY23FY25
Dec 25: capex $0.2 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.50.20.30.10.2−0.10.1−0.20.0−0.3$ B$ B$0B$0BMar 23Jun 24Dec 25
0.50.20.30.10.2−0.10.1−0.20.0−0.3$ B$ B$0B$0BMar 23Jun 24Dec 25

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Cmb.Tech NV earns a ROE of 5% in FY25. That is up from a trough of −17% in FY21. Return on invested capital clears the cost of that capital by −0.4 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 8.4% net margin on 0.20× asset turns.

FY25 ROE is 5%, recovered from a FY21 trough of −17% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY25): 8.4% net margin × 0.20× asset turns × 3.21× balance-sheet leverage ≈ 5.4% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 5.9% − 6.3% = a −0.4 pp spread. The 6.3% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY25: ROE 5% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 6.3% cost of capital used on this page.
the climb back from FY21's −17%
ROEROIC (annual)WACC
80%54%28%1.7%−25%%5.3%8.8%FY21FY23FY25
80%54%28%1.7%−25%%5.3%8.8%FY21FY23FY25
Mar 26: ROIC 10.8% (TTM) vs WACC 6.3% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
48%35%22%8.9%−4.0%%10.8%13.3%Jun 23Sep 24Mar 26
48%35%22%8.9%−4.0%%10.8%13.3%Jun 23Sep 24Mar 26
11 · Dividend

Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.

Cmb.Tech NV paid $0.46 per share over the last four reported quarters, down 61.4% on a year ago. The most recent declaration was $0.20 for Mar 26. Against the current price of $15.9 that is a trailing yield of 2.89%, measured on dividends already paid rather than on a forecast.

Cmb.Tech NV paid $0.46 per share across the last four reported quarters, most recently $0.20 for Mar 26. That is down 61.4% against the same quarter a year earlier. Against the current price of $15.9 the trailing twelve months work out to 2.89% — trailing dividends measured against today's price, not a forward estimate.

Dividend per share by quarter Declared dividend per share, $ B, per reported quarter. 8 quarters on file.
latest $0.20 (Mar 26)
Dividend per share
0.90.60.40.20.0$ B$0BJun 23Sep 23Mar 24Sep 25Mar 26
0.90.60.40.20.0$ B$0BJun 23Mar 24Mar 26
12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Cmb.Tech NV carries total debt of $5.2 B against shareholder equity of $2.9 B as of Mar 26, a debt-to-equity of 1.78. On the annual view that ratio went from 0.00 in FY21 to 2.12 in FY25. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of $5.2 B against shareholder equity of $2.9 B — a debt-to-equity of 1.78. On the annual view, debt-to-equity went from 0.00 (FY21) to 2.12 (FY25). Read the returns on this page with that leverage in mind.

FY25: debt $5.5 B at 2.12× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
6.02.4×4.51.7×3.01.1×1.50.5×0.0−0.2×$ B×$6B2.12×FY21FY23FY25
6.02.4×4.51.7×3.01.1×1.50.5×0.0−0.2×$ B×$6B2.12×FY21FY23FY25
Mar 26: debt $5.2 B, debt-to-equity 1.78 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
6.12.4×4.61.7×3.01.1×1.50.5×0.0−0.2×$ B×$5B1.78×Jun 23Sep 24Mar 26
6.12.4×4.61.7×3.01.1×1.50.5×0.0−0.2×$ B×$5B1.78×Jun 23Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

No ownership or positioning reading is held for Cmb.Tech NV, so this section names the gap rather than filling it. At typical trading volumes those positions would take about 1.1 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

We hold no ownership or positioning reading for this stock, so this section says that plainly.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Cmb.Tech NV: the Z-score reads 0.87. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

🚨 Why it matters: a Z-score of 0.87 is inside the distress zone — the balance sheet is a real risk, not a detail.

The safety line in one sentence: the Z-score reads 0.87.

15 · Related companies · Oil & Gas Midstream
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Frontline plcFRO 75.0/100Favorable setup81% evidence ASLEEP 29.1/35 Revenue 18.5% · PAT 100% · OPM change 60.1 pp 83% evidence 16.9/25 ROCE 10.8% · OPM 81.9% 76% evidence 15.4/20 P/E 8.6× · PEG 0.19 65% evidence 13.6/20 RS sector 12.8% · RS bench 17.7% · 1Y 103.6%3 of 12 weeks ahead 100% evidence
Exact sum: 29.1 + 16.9 + 15.4 + 13.6 = 75 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2International Seaways, Inc.INSW 73.9/100Favorable setup81% evidence FADING 26.9/35 Revenue 14.5% · PAT 69.3% · OPM change 57.6 pp 83% evidence 16.5/25 ROCE 11.2% · OPM 89.9% 76% evidence 16.4/20 P/E 6.6× · PEG 0.09 65% evidence 14.1/20 RS sector 23.7% · RS bench 29% · 1Y 116%7 of 12 weeks ahead 100% evidence
Exact sum: 26.9 + 16.5 + 16.4 + 14.1 = 73.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3BW LPG LimitedBWLP 68.7/100Favorable setup81% evidence TURNING 24.3/35 Revenue 5.1% · PAT 31.4% · OPM change 23.6 pp 83% evidence 15.3/25 ROCE 8% · OPM 26.2% 76% evidence 15.2/20 P/E 7.3× · PEG 0.28 65% evidence 13.9/20 RS sector 12.1% · RS bench 17.6% · 1Y 44.9%6 of 12 weeks ahead 100% evidence
Exact sum: 24.3 + 15.3 + 15.2 + 13.9 = 68.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Cmb.Tech NVthis pageCMBT 64.5/100Mixed-positive evidence71% evidence FADING 24.5/35 Revenue 100% · PAT 12.5% · OPM change 40.9 pp 83% evidence 13.2/25 ROCE 5.8% · OPM 84.6% 76% evidence 11.2/20 P/E 7.9× · PEG — 15% evidence 15.6/20 RS sector 13.3% · RS bench 18.8% · 1Y 75.5%6 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 13.2 + 11.2 + 15.6 = 64.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Targa Resources Corp.TRGP 60.9/100Mixed-positive evidence81% evidence BREAKING OUT 21.2/35 Revenue 1.1% · PAT 44.2% · OPM change 8.8 pp 83% evidence 12.9/25 ROCE 3.9% · OPM 20.7% 76% evidence 12.6/20 P/E 25.6× · PEG 0.45 65% evidence 14.2/20 RS sector 6.2% · RS bench 11.1% · 1Y 59.3%3 of 12 weeks ahead 100% evidence
Exact sum: 21.2 + 12.9 + 12.6 + 14.2 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Scorpio Tankers Inc.STNG 58.7/100Thin evidence · provisional58% evidence ASLEEP 23.1/35 Revenue — · PAT — · OPM change 42 pp 45% evidence 15.3/25 ROCE 9.8% · OPM 70.2% 76% evidence 11.5/20 P/E 4.3× · PEG — 15% evidence 8.8/20 RS sector -1.4% · RS bench 3.5% · 1Y 67.2%1 of 12 weeks ahead 100% evidence
Exact sum: 23.1 + 15.3 + 11.5 + 8.8 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7Venture Global, Inc.VG 55.6/100Mixed-positive evidence81% evidence TURNING 17.1/35 Revenue 100% · PAT 81.5% · OPM change -12.3 pp 83% evidence 9.3/25 ROCE 2.4% · OPM 25% 76% evidence 14.8/20 P/E 17.5× · PEG 0.14 65% evidence 14.4/20 RS sector -1.5% · RS bench 3.1% · 1Y 4%5 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 9.3 + 14.8 + 14.4 = 55.6 · Decision use: Price leads the evidence: RS versus the benchmark is 3.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
8Western Midstream Partners, LPWES 55.3/100Mixed-positive evidence81% evidence TURNING 14.5/35 Revenue 11.4% · PAT -6.5% · OPM change -2.9 pp 83% evidence 14.2/25 ROCE 3.8% · OPM 41.8% 76% evidence 15.2/20 P/E 13.5× · PEG 0.17 65% evidence 11.4/20 RS sector -4.1% · RS bench 1.7% · 1Y 22.5%3 of 12 weeks ahead 100% evidence
Exact sum: 14.5 + 14.2 + 15.2 + 11.4 = 55.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
9Enterprise Products Partners L.P.EPD 54.1/100Thin evidence · provisional58% evidence ASLEEP 22.4/35 Revenue — · PAT — · OPM change 1.8 pp 45% evidence 14.0/25 ROCE 7.2% · OPM 13.2% 76% evidence 10.9/20 P/E 12.7× · PEG — 15% evidence 6.8/20 RS sector -6.8% · RS bench -1.5% · 1Y 21.2%0 of 12 weeks ahead 100% evidence
Exact sum: 22.4 + 14 + 10.9 + 6.8 = 54.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10Plains All American Pipeline, L.P.PAA 51.9/100Mixed-positive evidence81% evidence TURNING 17.1/35 Revenue -7.1% · PAT 45.4% · OPM change 0.1 pp 83% evidence 6.9/25 ROCE 1.7% · OPM 3.2% 76% evidence 12.7/20 P/E 18.5× · PEG 0.49 65% evidence 15.2/20 RS sector 1.1% · RS bench 6.4% · 1Y 31.9%4 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 6.9 + 12.7 + 15.2 = 51.9 · Decision use: Price leads the evidence: RS versus the benchmark is 6.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
11South Bow CorporationSOBO 49.2/100Mixed-negative evidence81% evidence ASLEEP 13.4/35 Revenue -4.6% · PAT 44.5% · OPM change -3.1 pp 83% evidence 10.3/25 ROCE 1.7% · OPM 32.6% 76% evidence 13.5/20 P/E 16.4× · PEG 0.36 65% evidence 12.0/20 RS sector -0.8% · RS bench 4.5% · 1Y 32%3 of 12 weeks ahead 100% evidence
Exact sum: 13.4 + 10.3 + 13.5 + 12 = 49.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
12Golar LNG LimitedGLNG 48.6/100Mixed-negative evidence81% evidence ASLEEP 27.9/35 Revenue 81.5% · PAT 100% · OPM change 76.5 pp 83% evidence 11.7/25 ROCE 2.7% · OPM 81.8% 76% evidence 4.3/20 P/E 42.3× · PEG 2.76 65% evidence 4.7/20 RS sector -6.1% · RS bench -1.3% · 1Y 22.2%2 of 12 weeks ahead 100% evidence
Exact sum: 27.9 + 11.7 + 4.3 + 4.7 = 48.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.1% and the one-year return is 22.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
13Pembina Pipeline CorporationPBA 48.2/100Mixed-negative evidence81% evidence TURNING 13.0/35 Revenue -6.5% · PAT -12.8% · OPM change 2.7 pp 83% evidence 11.3/25 ROCE 2.3% · OPM 37.3% 76% evidence 13.2/20 P/E 23.4× · PEG 0.33 65% evidence 10.7/20 RS sector -3.4% · RS bench 2% · 1Y 36.3%3 of 12 weeks ahead 100% evidence
Exact sum: 13 + 11.3 + 13.2 + 10.7 = 48.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
14Hess Midstream LPHESM 48.1/100Mixed-negative evidence81% evidence TURNING 13.0/35 Revenue 7% · PAT 3.6% · OPM change -1.1 pp 83% evidence 15.4/25 ROCE 5.8% · OPM 61% 76% evidence 12.2/20 P/E 13.4× · PEG 1.01 65% evidence 7.5/20 RS sector -8.1% · RS bench -2.7% · 1Y -3.3%1 of 12 weeks ahead 100% evidence
Exact sum: 13 + 15.4 + 12.2 + 7.5 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Excelerate Energy, Inc.EE 46.9/100Mixed-negative evidence81% evidence BREAKING OUT 14.2/35 Revenue 39.4% · PAT -6.8% · OPM change -2 pp 83% evidence 10.4/25 ROCE 2.5% · OPM 18.9% 76% evidence 4.1/20 P/E 27.2× · PEG 3.91 65% evidence 18.2/20 RS sector 4.8% · RS bench 10.3% · 1Y 61.2%4 of 12 weeks ahead 100% evidence
Exact sum: 14.2 + 10.4 + 4.1 + 18.2 = 46.9 · Decision use: Price leads the evidence: RS versus the benchmark is 10.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
16Kinetik Holdings Inc.KNTK 46.4/100Mixed-negative evidence81% evidence ASLEEP 16.2/35 Revenue 9.3% · PAT 100% · OPM change -5.2 pp 83% evidence 5.1/25 ROCE -0.1% · OPM -0.9% 76% evidence 13.9/20 P/E 19.8× · PEG 0.27 65% evidence 11.2/20 RS sector -3.3% · RS bench 1.9% · 1Y 17.9%0 of 12 weeks ahead 100% evidence
Exact sum: 16.2 + 5.1 + 13.9 + 11.2 = 46.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Antero Midstream CorporationAM 46.3/100Thin evidence · provisional58% evidence ASLEEP 16.3/35 Revenue — · PAT — · OPM change -0.9 pp 45% evidence 14.4/25 ROCE 3.1% · OPM 60% 76% evidence 9.3/20 P/E 27.1× · PEG — 15% evidence 6.3/20 RS sector -7.5% · RS bench -2.5% · 1Y 18.5%0 of 12 weeks ahead 100% evidence
Exact sum: 16.3 + 14.4 + 9.3 + 6.3 = 46.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18The Williams Companies, Inc.WMB 46.2/100Mixed-negative evidence81% evidence ASLEEP 21.6/35 Revenue 10.7% · PAT 22.3% · OPM change 7.7 pp 83% evidence 12.8/25 ROCE 2.5% · OPM 43.6% 76% evidence 8.6/20 P/E 31.9× · PEG 1.46 65% evidence 3.2/20 RS sector -9.2% · RS bench -4.2% · 1Y 23.5%0 of 12 weeks ahead 100% evidence
Exact sum: 21.6 + 12.8 + 8.6 + 3.2 = 46.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19ONEOK, Inc.OKE 45.3/100Mixed-negative evidence81% evidence ASLEEP 18.6/35 Revenue 41% · PAT 12.1% · OPM change -0.4 pp 83% evidence 10.7/25 ROCE 2.4% · OPM 14.8% 76% evidence 8.9/20 P/E 16.1× · PEG 1.68 65% evidence 7.1/20 RS sector -7.4% · RS bench -2.3% · 1Y 17.7%1 of 12 weeks ahead 100% evidence
Exact sum: 18.6 + 10.7 + 8.9 + 7.1 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Cheniere Energy Partners, L.P.CQP 45.1/100Mixed-negative evidence81% evidence TURNING 11.2/35 Revenue 21% · PAT 2.5% · OPM change -17.6 pp 83% evidence 9.0/25 ROCE 2.4% · OPM 10% 76% evidence 13.5/20 P/E 15.1× · PEG 0.48 65% evidence 11.4/20 RS sector -3.8% · RS bench 1.6% · 1Y 21.1%0 of 12 weeks ahead 100% evidence
Exact sum: 11.2 + 9 + 13.5 + 11.4 = 45.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
21Kinder Morgan, Inc.KMI 45.1/100Thin evidence · provisional58% evidence ASLEEP 21.2/35 Revenue — · PAT — · OPM change 2.9 pp 45% evidence 10.8/25 ROCE 2% · OPM 29.9% 76% evidence 9.7/20 P/E 20.5× · PEG — 15% evidence 3.4/20 RS sector -11% · RS bench -6% · 1Y 16.7%0 of 12 weeks ahead 100% evidence
Exact sum: 21.2 + 10.8 + 9.7 + 3.4 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Energy Transfer LPET 45.0/100Mixed-negative evidence81% evidence TURNING 14.9/35 Revenue 12.5% · PAT -9.5% · OPM change -1.2 pp 83% evidence 10.8/25 ROCE 2.5% · OPM 10.7% 76% evidence 9.3/20 P/E 16.1× · PEG 1.67 65% evidence 10.0/20 RS sector -5.2% · RS bench 0.3% · 1Y 17.7%0 of 12 weeks ahead 100% evidence
Exact sum: 14.9 + 10.8 + 9.3 + 10 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23MPLX LPMPLX 43.5/100Mixed-negative evidence81% evidence TURNING 11.1/35 Revenue 3.1% · PAT 5.8% · OPM change -4.1 pp 83% evidence 13.4/25 ROCE 2.8% · OPM 36.1% 76% evidence 9.0/20 P/E 12.4× · PEG 1.84 65% evidence 10.0/20 RS sector -6.4% · RS bench -0.7% · 1Y 20%1 of 12 weeks ahead 100% evidence
Exact sum: 11.1 + 13.4 + 9 + 10 = 43.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24Plains GP Holdings, L.P.PAGP 43.1/100Mixed-negative evidence64% evidence TURNING 13.2/35 Revenue -7.1% · PAT — · OPM change 0.1 pp 62% evidence 4.3/25 ROCE 1.6% · OPM 3.2% 76% evidence 9.5/20 P/E 25× · PEG — 15% evidence 16.1/20 RS sector 1.9% · RS bench 7.2% · 1Y 32.3%5 of 12 weeks ahead 100% evidence
Exact sum: 13.2 + 4.3 + 9.5 + 16.1 = 43.1 · Decision use: Price leads the evidence: RS versus the benchmark is 7.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
25TC Energy CorporationTRP 40.1/100Thin evidence · provisional58% evidence ASLEEP 18.0/35 Revenue — · PAT — · OPM change 1.7 pp 45% evidence 8.7/25 ROCE 1.6% · OPM 47.5% 76% evidence 9.0/20 P/E 28.2× · PEG — 15% evidence 4.4/20 RS sector -6.8% · RS bench -1.7% · 1Y 32.4%3 of 12 weeks ahead 100% evidence
Exact sum: 18 + 8.7 + 9 + 4.4 = 40.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
26DT Midstream, Inc.DTM 39.9/100Thin evidence · provisional58% evidence ASLEEP 18.4/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 11.2/25 ROCE 1.8% · OPM 49.4% 76% evidence 8.7/20 P/E 32.1× · PEG — 15% evidence 1.6/20 RS sector -9.8% · RS bench -4.8% · 1Y 28.9%0 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 11.2 + 8.7 + 1.6 = 39.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
27Viper Energy, Inc.VNOM 35.5/100Mixed-negative evidence71% evidence BASING 12.0/35 Revenue 84.3% · PAT -121.9% · OPM change -13.8 pp 83% evidence 12.4/25 ROCE 2.8% · OPM 49.5% 76% evidence 10.4/20 P/E 15.8× · PEG — 15% evidence 0.7/20 RS sector -13.9% · RS bench -9.1% · 1Y 12%0 of 12 weeks ahead 100% evidence
Exact sum: 12 + 12.4 + 10.4 + 0.7 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Enbridge Inc.ENB 34.6/100Thin evidence · provisional58% evidence BASING 15.9/35 Revenue — · PAT — · OPM change -5.4 pp 45% evidence 7.3/25 ROCE 1.4% · OPM 14.4% 76% evidence 8.9/20 P/E 29.7× · PEG — 15% evidence 2.5/20 RS sector -11.6% · RS bench -6.5% · 1Y 13.7%0 of 12 weeks ahead 100% evidence
Exact sum: 15.9 + 7.3 + 8.9 + 2.5 = 34.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Cheniere Energy, Inc.LNG 32.4/100Adverse evidence81% evidence TURNING 8.3/35 Revenue 20.8% · PAT -37.2% · OPM change -77.1 pp 83% evidence 3.8/25 ROCE -8.8% · OPM -59.4% 76% evidence 10.5/20 P/E 46.7× · PEG 0.9 65% evidence 9.8/20 RS sector -6.4% · RS bench -1.2% · 1Y 11.5%0 of 12 weeks ahead 100% evidence
Exact sum: 8.3 + 3.8 + 10.5 + 9.8 = 32.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
30SunocoCorp LLCSUNC 51.4/100Thin evidence · provisional23% evidence BREAKING OUT 18.4/35 Revenue — · PAT — · OPM change 2.3 pp 10% evidence 13.0/25 ROCE 6.8% · OPM 8.1% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —5 of 12 weeks ahead 0% evidence
Exact sum: 18.4 + 13 + 10 + 10 = 51.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Cmb.Tech NV's stock price today?

Cmb.Tech NV trades at $15.9, +77.3% over the past year. The company is valued at $5.0 B. The stock sits at 89% of its 52-week range of $8–$17, +24.9% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 22 weeks in. — as of 5 August 2026.

What were Cmb.Tech NV's latest quarterly results?

Cmb.Tech NV reported revenue of $0.5 B and net profit of $0.4 B for the Mar 26 quarter. Revenue rose 116.7% and profit rose 825.0% year on year. Earnings per share were $1.27. The operating margin was 84.6%, 42.9 pp higher than a year earlier. — as of 5 August 2026.

What is Cmb.Tech NV's revenue?

Cmb.Tech NV reported revenue of $0.5 B in the Mar 26 quarter, +116.7% year on year. For the full FY25 fiscal year, revenue was $1.7 B (+77.7%). Over the last 4 years revenue compounded at 41.2% a year. — as of 5 August 2026.

What is Cmb.Tech NV's profit?

Cmb.Tech NV earned $0.4 B of net profit in the Mar 26 quarter, +825.0% year on year. Full-year FY25 profit was $0.1 B. The operating margin ran 84.6% in the latest quarter. — as of 5 August 2026.

What is Cmb.Tech NV's market cap?

Cmb.Tech NV's market capitalisation is $5.0 B at a stock price of $15.9. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is Cmb.Tech NV's P/E ratio?

Cmb.Tech NV trades at a P/E of 9.6×, at the 76th percentile of its own 4-year range, against a long-run median of 5.3×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does Cmb.Tech NV pay a dividend?

Yes — Cmb.Tech NV declared $0.20 per share for Mar 26, and $0.46 per share across the last four reported quarters. The latest quarter is down 61.4% on the same quarter a year earlier. — as of 5 August 2026.

What is Cmb.Tech NV's dividend per share?

Cmb.Tech NV's most recently declared dividend is $0.20 per share for Mar 26, giving $0.46 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.

What is Cmb.Tech NV's dividend yield?

Cmb.Tech NV's trailing dividend yield is 2.89%: $0.46 declared per share across the last four reported quarters, against a share price of $15.9. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.

Is Cmb.Tech NV overvalued?

On its own history, Cmb.Tech NV looks expensive against its own history: its P/E of 9.6× sits at the 76th percentile of its 4-year range (long-run median 5.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.

Is Cmb.Tech NV growing?

Yes — Cmb.Tech NV is growing: latest-quarter revenue +116.7% year on year, profit +825.0%, and the margin +42.9 pp at 84.6%. The earnings engine currently reads: improving — as of 5 August 2026.

How is Cmb.Tech NV performing?

Cmb.Tech NV is in a confirmed uptrend, 22 weeks in. Its latest quarter's revenue rose 116.7% and profit rose 825.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

What stage is Cmb.Tech NV in?

Turning around — profit growth swung from −83.9% at the trough to +14.6% off a 1-quarter-old trough, ROCE lifting at 11.8%. The read comes from the last 12 quarters of growth (revenue growth +107.4% latest, profit growth +14.6% latest, eps growth −25.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.

Is Cmb.Tech NV in an uptrend?

Yes — the price is in a confirmed uptrend (week 22 of stage 2), trading +24.9% versus its 200-day average and at 89% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is Cmb.Tech NV beating the market?

On recent form, yes — Cmb.Tech NV has been ahead of the S&P 500 on a trailing-13-week view for 5 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +83% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.

Will Cmb.Tech NV's stock price go up?

This page publishes no price forecast for Cmb.Tech NV. What it measures instead: the stock price is $15.9, the price is in a confirmed uptrend 22 weeks in. Its P/E of 9.6× sits at the 76th percentile of its own 4-year range. — as of 5 August 2026.

Does Cmb.Tech NV have too much debt?

It carries real leverage — Cmb.Tech NV's debt-to-equity is 1.78. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.

What is Cmb.Tech NV's capex?

Cmb.Tech NV spent $2.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $1.0 B. — as of 5 August 2026.

What is Cmb.Tech NV's cash flow?

Cmb.Tech NV generated $0.4 B of operating cash flow in FY25 and $−0.6 B of free cash flow after $1.0 B of capital spending. Reported profit that year was $0.1 B, so operating cash ran ahead of profit. — as of 5 August 2026.

Is Cmb.Tech NV's profit real cash?

Yes — over the last 3 fiscal years, 93% of Cmb.Tech NV's reported profit arrived as operating cash. In FY25, operating cash was $0.4 B against reported profit of $0.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.

How financially safe is Cmb.Tech NV?

On the balance sheet, the Z-score reads 0.87 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.

Where is Cmb.Tech NV in its business cycle?

Cmb.Tech NV's FY25 operating margin was 33.5%, against a 5-year band of −66.7%–106.4%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 84.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Cmb.Tech NV story?

The sharpest disagreement: the price moved +77.3% in a year while annual EPS moved −84.2% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Cmb.Tech NV a stock worth studying right now?

This is not investment advice. The machine read: Cmb.Tech NV's price has outrun its earnings. +77.3% in a year against EPS −84.2% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI